pharmaceuticals
Shockingly Few Pharma Ads Comply With FDA Guidelines
1:30PM 8/25/2011
Officially, it's the FDA's job to ensure that pharmaceutical ads adhere to guidelines. But the agency's annual compliance budget is $9 million, while drug companies spend $58 billion a year on marketing. So it comes as no surprise that only 18% of ads are in compliance with the rules. But it's still disturbing: This is your health.
Do you want your new prescription drugs to be made under last century's oversight? Like it or not, that's likely what you're getting -- or worse -- because increasingly, Americans' medicines are made overseas in place where the oversight isn't up to U.S. standards.
Pfizer Sells Capsugel: Will More Asset Sales Follow?
2:15PM 4/04/2011
On Monday, Pfizer announced it would sell its Capsugel business to private-equity firm KKR for $2.375 billion. If the hints the drugmaker has been giving lately are true, the move could be the start of two years of major asset sales. Here's what's ahead for the world's biggest pharmaceutical company.
WHO's Swine Flu Pandemic Response Wasn't Influenced by Vaccine Makers
3:30PM 3/10/2011
Health Care, Sanofi Aventis, GlaxoSmithKline, Novartis, Astrazeneca
During the H1N1 swine flu pandemic, much criticism was leveled at World Health Organization officials, accusing their response of being too heavily influenced by the pharmaceutical industry. But according to a panel of independent experts, that wasn't the case.
FDA Approves First New Lupus Drug in Half a Century
7:15PM 3/09/2011
The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in 56 years. It's not terribly effective: It only worked for 35% of the patients tested. But experts say the approval could prompt the development of more effective drugs.
In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research and development cuts were on the way.
The 10 Biggest-Selling Drugs That Are About to Lose Their Patent
8:00AM 2/27/2011
Company News, Investing, Health Care, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Merck, Eli Lilly, Astrazeneca
The pharmaceutical industry is ready to fall off a cliff -- a "patent cliff." Over the next few years, some of the world's most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from drugmakers' bottom lines.
Vertex Pharmaceutical shares soared 15% Wednesday as Wall Street cheered the results of a late-stage study of its new cystic fibrosis drug, an experimental treatment that targets the underlying cause of the disease rather than just its symptoms.
Pharmaceuticals Look Beyond Medications to Smartphone Apps
11:10AM 2/16/2011
Health Care, Pfizer, Qualcomm, Apple, Sanofi Aventis, Merck, GlaxoSmithKline, Novartis, Cisco Systems
Pharmaceutical companies looking for fresh sources of profit are increasingly investing in a range of health care innovations that aren't drugs at all, from smartphone apps and educational websites to social media platforms and wireless devices, reports Ernst & Young.
Still No Deal Between Sanofi-Aventis and Genzyme
12:45PM 2/11/2011
What is preventing the French pharmaceutical group and U.S. biotech from reaching a merger agreement?
More Stories
Next Page →Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.08 | -0.11 -1.28% | 184.54M | |
| 2.21 | +0.27 +13.66% | 107.06M | |
| 12.45 | -0.25 -1.93% | 35.97M | |
| 18.84 | -0.30 -1.54% | 33.77M |
% Gainers
| 31.71 | +7.81 +32.68% | 15.75M | |
| 89.60 | +13.21 +17.29% | 10.41M | |
| 2.21 | +0.27 +13.66% | 107.06M | |
| 10.55 | +1.15 +12.23% | 2.78M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Greek PM says default would lead to 'chaos'
- Budget deficit drops to $27 billion in January
- Turbo-traders take Bank of America for a ride
- Stocks fall sharply as Greek deal is held up
- Bernanke: Weak housing has hurt consumer...
- Trade deficit widens to $48.8 billion in...
- Feds investigate door fires in 2007 Camrys,...
- Review: Netflix and Hulu's new scripted...
- Mid-day Movers (CIE, AMRS, IPSU, MOVE, LNKD)
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
- 2011 Trade Deficit Hits 3-Year High, Over $550 Billion
- Today’s Best Market Rumors (2/10/2012) Apple iPad, Google Entertainment
- Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF, TRLG)
Follow Us
